Patent US5205285A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5205285A Expired / Lapsed US ⏱️ 0.0 years remaining

Voice suppression of vagal stimulation

Assignee: Livanova USA Inc
•
Filing: 1991-06-14
•
Granted: 1993-04-27
•
Expires: 2011-06-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract In conjunction with a medical device for stimulating the vagus nerve of a patient to modulate the electrical activity thereof as part of a prescribed therapy, apparatus is provided to selectively suppress the stimulation while the patient is speaking, to avoid undesirable modulation of the voice. The suppression apparatus includes a speech sensor and discriminator, to detect speech by the patient while avoiding false detection attributable to sounds other than speech. The suppression of nerve stimulation is ceased after a preset time interval regardless of continued detection of speech, to assure that beneficial therapy is not unduly inhibited in favor of mere cosmetic considerations or in the presence of prolonged false detections. In the preferred embodiment, the discriminator selectively varies the sensitivity of the suppression apparatus to speech by the patient to enhance its selectivity over sounds attributable to other sources, such as by changing the value of a threshold level which must be crossed before the suppression of nerve stimulation can occur or continue, and by filtering out disturbances.

Inventors

  • 👤 Ross G. Baker, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 10:16
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/18; A61N1/32; A61N1/36; A61N1/3605; A61N1/36128; A61N1/36135; A61N1/36053

Claims Analysis

Total Claims: 23
Claim 1
Independent Claim 55 words
A medical device for stimulating the vagus nerve of a patient to modulate the electrical activity thereof as part of a prescribed therapy, comprising: signal generating means for generating a predetermined signal to stimulate the vagus nerve, and sensing means responsive to speech by the patient for automatically inhibiting said signal from stimulating the nerve.
Claim 2
Dependent Claim 55 words
A medical device for stimulating the vagus nerve of a patient to modulate the electrical activity thereof as part of a prescribed therapy, comprising: signal generating means for generating a predetermined signal to stimulate the vagus nerve, and sensing means responsive to speech by the patient for automatically inhibiting said signal from stimulating the nerve.
Claim 3
Dependent Claim 17 words
The invention of claim 1, wherein said sensing means includes means for detecting speech by the patient.
Claim 4
Dependent Claim 32 words
The invention of claim 2, wherein said sensing means further includes means for removing the inhibition after a preset time interval regardless of continued detection of speech by the speech detecting means.
Claim 5
Dependent Claim 27 words
The invention of claim 2, wherein said sensing means further includes means for discriminating speech by the patient from other sounds to avoid false detection of speech.
Claim 6
Dependent Claim 34 words
The invention of claim 2, wherein said sensing means further includes for varying the sensitivity of the speech detecting means to speech by the patient, to reduce the likelihood of false detection of speech.
Claim 7
Dependent Claim 32 words
The invention of claim 5, wherein said sensing means further includes means for removing the inhibition after a preset time interval regardless of continued detection of speech by the speech detecting means.
Claim 8
Dependent Claim 36 words
The invention of claim 5, wherein the sensitivity varying means includes means for progressively decreasing the sensitivity of the speech detecting means to speech-generated phenomena, to discriminate against similar phenomena generated by sources other than speech.
Claim 9
Dependent Claim 55 words
The invention of claim 5, wherein the sensing means further includes means for setting a threshold value of the speech detecting means representing a predetermined sensitivity to patient speech, and the sensitivity varying means includes means for progressively increasing the threshold value of the speech detecting means to speech-generated phenomena, with increasing intervals of inhibition.
Claim 10
Dependent Claim 14 words
The invention of claim 4, wherein the speech detecting means includes a vibration sensor.
Claim 11
Dependent Claim 49 words
The invention of claim 9, wherein the vibration sensor includes transducer means for converting detected vibrations to an electrical signal, and the speech discriminating means includes bandpass filter means for processing the electrical signal derived from the detected vibrations while substantially rejecting signal frequencies outside the voice frequency band.
Claim 12
Dependent Claim 31 words
The invention of claim 1, wherein said sensing means includes means for removing the inhibition after a preset time interval regardless of continued detection of speech by the speech detecting means.
Claim 13
Dependent Claim 58 words
The invention of claim 1, wherein the sensing means includes means for summing the time intervals of inhibition of the signal generated by said signal generating means during a predetermined period, and means for reducing the time intervals of subsequent inhibitions when the sum of the time intervals of inhibition during said predetermined period exceeds a present value.
Claim 14
Dependent Claim 45 words
In conjunction with a medical device for stimulating the vagus nerve of a patient to modulate the electrical activity of the nerve as part of a prescribed therapy, the improvement comprising: sensing means responsive to speaking by the patient for automatically suppressing the nerve stimulation.
Claim 15
Dependent Claim 45 words
In conjunction with a medical device for stimulating the vagus nerve of a patient to modulate the electrical activity of the nerve as part of a prescribed therapy, the improvement comprising: sensing means responsive to speaking by the patient for automatically suppressing the nerve stimulation.
Claim 16
Dependent Claim 36 words
The improvement of claim 13, wherein said sensing means includes means for restoring the capability of the device to further stimulate the vagus nerve after a preset time interval regardless of continued speaking by the patient.
Claim 17
Dependent Claim 25 words
The improvement of claim 14, wherein said sensing means further includes means for distinguishing speaking by the patient from other phenomena to avoid false responses.
Claim 18
Dependent Claim 21 words
The improvement of claim 13, wherein said sensing means includes means for disabling the suppression despite continued speech by the patient.
Claim 19
Dependent Claim 33 words
The improvement of claim 13, wherein said sensing means includes means for varying the sensitivity of the device to speech by the patient, after a predetermined time interval in which stimulation is suppressed.
Claim 20
Independent Claim 61 words
A method of avoiding undesirable modulation of the voice of a patient as a consequence of stimulation of the patient's vagus nerve by a medical device to modulate the electrical activity of the nerve as part of a prescribed therapy, said method comprising: sensing speech by the patient, and responding to said sensing of speech by automatically suppressing the nerve stimulation.
Claim 21
Independent Claim 61 words
A method of avoiding undesirable modulation of the voice of a patient as a consequence of stimulation of the patient's vagus nerve by a medical device to modulate the electrical activity of the nerve as part of a prescribed therapy, said method comprising: sensing speech by the patient, and responding to said sensing of speech by automatically suppressing the nerve stimulation.
Claim 22
Dependent Claim 26 words
The method of claim 18, further including restoring the availability of stimulation after a preset time interval regardless of continued sensing of speech by the patient.
Claim 23
Dependent Claim 27 words
The method of claim 18, further including distinguishing speech by the patient from other sounds to avoid suppression of stimulation in response to false detection of speech.

References Cited (Backward Citations)

US4791931A Cited
US5111814A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-04-26 1996-10-26 1997-04-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-04-26 2000-10-26 2001-04-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-04-26 2004-10-26 2005-04-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag